With HSAs, employers turning to the 401(k) playbook

In 2025, nearly 46% of employers automatically enrolled workers into HSAs when they had high-deductible health plans—up from 32% in 2019—mirroring the broader adoption of auto-enrollment (64% auto-enrolled into 401(k)s in 2025). Employers are also increasingly funding HSAs (77% provided an employer contribution in 2025) and introducing 401(k)-style matching (about 10% of contributors match employee HSA contributions, with 7.5% considering it). Combined with Secure 2.0’s push for auto-enrollment in retirement plans and HSA tax advantages, the trend supports higher HSA uptake to help offset rising out-of-pocket healthcare costs.

Analysis

This is a slow-burn beneficiary set-up, not a one-day headline trade. Auto-enrollment turns HSA adoption into a default behavior, which should lift funded account counts and reduce customer acquisition friction for HSA administrators such as HQY and WEX, but the market may be overpaying for that because the monetization quality depends on how quickly balances migrate out of cash and into fee-generating investments.

The first-order winner is the platform layer, not the medical cost payer. More employer seeding and matching should raise stickiness and improve retention of pay-roll linked deposits, while also creating cross-sell into brokerage-like features; second-order, that can modestly aid low-cost asset gatherers and custodians, but it is a mixed bag if cash balances remain parked and spread income gets hit by falling rates. That makes the trade more sensitive to the Fed path than the policy narrative suggests.

On the loser side, the effect on managed care and provider names is ambiguous: lower-premium HDHPs can expand enrollment, but they also shift more cost to consumers and can suppress utilization at the margin. The cleaner short would be any name whose revenue is heavily tied to rich plan mix or elective utilization, but this is a weak signal and likely not enough for a standalone short without confirmation from enrollment data.

The contrarian view is that the consensus is treating HSA growth like a retirement-account secular winner, when in practice many accounts will remain small, cash-heavy, and rate-sensitive. The key falsifier is a sharp slowdown in employer guidance for 2026 plan design or a policy pushback against HDHPs/HSA tax advantages; absent that, the best catalyst window is the Q4 benefits season, with the structural story playing out over 6-18 months rather than days.

Key Decisions for Investors

• Long HQY on any post-open-enrollment pullback; 3-6 month horizon. Thesis: account growth and sponsor stickiness improve, but trim if guidance shows funded balances rising without a commensurate shift into invested assets.
• Prefer WEX as the lower-beta way to express HSA adoption; hold 6-12 months. Risk/reward is better if you want diversified exposure to benefits administration rather than a pure-play valuation rerate.
• Relative-value: long HQY / short XLV as a basket proxy if you want to isolate consumer-directed healthcare adoption versus broader healthcare. This works best if 2026 open-enrollment commentary confirms higher HSA enrollment and matching behavior.
• If the Fed signals a faster easing path, reduce HSA administrator exposure or hedge it, because net interest income on custodial cash can compress faster than account growth expands.
• Watch item, not a trade yet: managed-care names with heavy exposure to lower-premium employer plans. Only short if we see evidence that utilization suppression and plan-mix dilution outweigh the offset from higher enrollment.